Intelligence · Patents
Patents expiring in 2042
Annual patent cliff calendar for 2042 — US pharmaceutical patents by expiration date.
- Patents
- 1,738
Quick answer
1,738 indexed pharmaceutical patents have expiration dates in 2042. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 11338033
Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
granted -
US 11339112
Compositions and methods comprising resveratrol
granted -
US 11338119
Implantable drug delivery devices for localized drug delivery
granted -
US 11338028
Cancer vaccines targeting LEMD1 and uses thereof
granted -
US 11338026
Identification of immunologically protective neo-epitopes for the treatment of cancers
granted -
US 11338013
Combination therapy for C3 inhibition
granted -
CA 3198740
METHODES DE TRAITEMENT D'UN REJET A MEDIATION PAR ANTICORPS
granted -
CA 3198544
PROCEDES D'AUGMENTATION DE LA TAILLE ET DE PROMOTION DE LA CROISSANCE OSSEUSE LINEAIRE
granted -
US 11345694
Antibacterial compounds
granted -
US 11345894
Cellular seeding and co-culture of a three dimensional fibroblast construct
granted -
US 11344615
Nucleic acids encoding chimeric dengue/Zika viruses optimized for growth and stability in vero cells
granted -
US 11344626
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
granted -
US 11344580
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted -
US 11345700
Methods of preparing inhibitors of influenza viruses replication
granted -
US 11344513
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11344568
Methods and compositions for administration of iron
granted -
US 11345715
Biologically active molecules, conjugates thereof, and therapeutic uses
granted -
US 11345928
Modified immunization vectors
granted -
US 11345930
Codon optimized RPGRORF15 genes and uses thereof
granted -
US 11345904
Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof
granted -
US 11345734
Chimeric T cell
granted -
US 11345733
Colon and pancreas cancer specific antigens and antibodies
granted -
US 11345702
PGDH inhibitors and methods of making and using
granted -
US 11345705
Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists
granted -
US 11345659
Pipecolic esters for inhibition of the proteasome
granted -
US 11344707
Devices for applying a topical treatment
granted -
US 11344631
Promoter for cell-specific gene expression and uses thereof
granted -
US 11345658
Compounds and compositions comprising the same for treating hypertension or heart failure
granted -
US 11344652
Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices
granted -
US 11345653
Compositions and methods for reactivating cholinesterases
granted -
US 11344605
Therapeutic use of inhibitors of t cell activation or stimulation
granted -
US 11344581
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted -
US 11344618
HIV envelope glycoprotein immunogens
granted -
US 11344610
Prevention and reduction of blood loss
granted -
US 11344609
Compositions and methods for treating hemoglobinopathies
granted -
US 11344579
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11344578
Immune cells expressing engineered antigen receptors
granted -
US 11344577
Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
granted -
US 11344575
Vascular calcification prevention and treatment
granted -
US 11344569
Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin
granted -
US 11344559
PI3KGAMMA inhibitors
granted -
US 11344538
Methods for the treatment of myopia
granted -
US 11344514
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11344557
Corticotropin releasing factor receptor antagonists
granted -
US 11344555
Nucleotide analogs
granted -
US 11344526
Implantable drug delivery devices for localized drug delivery
granted -
US 11344491
Compositions and methods of using the same for decontamination of skin
granted -
US 11345678
Benzopyrazole compound used as RHO kinase inhibitor
granted
Frequently asked questions
How many pharma patents expire in 2042?
1,738 published patents in our USPTO index have expiration dates falling in calendar year 2042.